Saturday, January 1, 2011
Marc Ladanyi has been named the incumbent of the newly endowed William Ruane Chair in Molecular Oncology.
Marc Ladanyi has been named the incumbent of the newly endowed William Ruane Chair in Molecular Oncology. The chair was made possible by a gift from the late William J. Ruane, a longtime supporter of Memorial Sloan Kettering.
Dr. Ladanyi is Attending Pathologist in Molecular Diagnostics Service of the Department of Pathology and Member in the Human Oncology and Pathogenesis Program. He is a molecular pathologist whose laboratory works on the genomics and molecular pathogenesis of sarcomas and thoracic malignancies. He also co-directs The Cancer Genome Atlas (TCGA) group at Memorial Sloan Kettering, part of the National Cancer Institute’s TCGA project network. He has authored or co-authored more than 195 primary research papers and more than 40 reviews and commentaries.
A noted investigator, Dr. Ladanyi has received Young Investigator Awards from the US and Canadian Academy of Pathology and from Memorial Sloan Kettering. In 2007 he was awarded the Nina Axelrod Lectureship by the Connective Tissue Oncology Society, and in 2009 received the Caine Halter Hope Now Award from Uniting Against Lung Cancer.